Steris PLC
STE
209.68
+1.03
+0.49%
Steris PLC
US · STE
#909 by market cap
Listed 1970
209.68
+1.03
+0.49%
Live - 5344 symbols - heartbeat 337s ago
· 2026-10-07 19:54
After-hours
209.68
0.00%
- Market cap
- 20.44B
- P/E (TTM)i
- 25.63
- P/Bi
- 2.84
- EPSi
- 7.93
- Div yieldi
- 1.20%
- 52W posi
- 21%
Reader sentiment
Are you bullish or bearish on STE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 100.36% -0.05pp
- Institutions
- 1,031 -3
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund84.39%
Hedge Fund7.56%
Public Company3.68%
Government Pension Fund1.41%
Sovereign Wealth Fund1.25%
Private Company1.18%
Individual/Insider0.33%
Insurance Company0.30%
Family Office/Trust0.26%
Top holders as of 2026-06-30
BlackRock
9.05% · 8.82M sh
Vanguard Capital Management, LLC
7.14% · 6.96M sh
State Street Global Advisors
5.20% · 5.07M sh
Vanguard Portfolio Management, LLC
5.13% · 5.00M sh
MFS Investment Management
3.90% · 3.80M sh
Wellington Management Group
3.59% · 3.50M sh
Orbis Investment Management Limited
2.75% · 2.68M sh
Geode Capital Management, LLC
2.68% · 2.62M sh
Morgan Stanley Investment Management Inc.
2.63% · 2.57M sh
Generation Investment Management LLP
2.34% · 2.28M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 24 buys · 26 sells
| Name | Role | Stake |
|---|---|---|
| Daniel Carestio | Chief Executive Officer | 0.07% |
| Michael Tokich | Senior Vice President | 0.05% |
| Richard Breeden | Independent Director | 0.04% |
| John Zangerle | Senior Vice President | 0.04% |
| Jacqueline Kosecoff | Independent Director | 0.03% |
| Mohsen Sohi | Independent Chairperson | 0.02% |
| Cary Majors | Senior Vice President & President of Healthcare | 0.02% |
| Mary Fraser | SVP & Chief Human Resources Officer | 0.01% |
| Karen Burton | Chief Accounting Officer, VP & Controller | 0.01% |
| Julia Madsen | Senior Vice President of Life Sciences | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Karen Burton | Chief Accounting Officer, VP & Controller | Sale to Issuer | -228 | -- |
| 2026-08-17 | Richard Breeden | Independent Director | Intent to Sell (Form 144) | -4,110 | $231.90 |
| 2026-08-11 | Mohsen Sohi | Independent Chairperson | Derivative Exercise and Sale | -4,058 | $86.23–235.78 |
| 2026-08-09 | Mohsen Sohi | Independent Chairperson | Other Derivative Acquisition | +1,099 | $238.91 |
| 2026-08-09 | Mohsen Sohi | Independent Chairperson | Other Derivative Acquisition | +1,229 | -- |
| 2026-08-09 | Cynthia Feldmann | Independent Director | Other Derivative Acquisition | +512 | -- |
| 2026-08-09 | Cynthia Feldmann | Independent Director | Other Derivative Acquisition | +1,506 | $238.91 |
| 2026-08-09 | Paul Martin | Independent Director | Other Derivative Acquisition | +512 | -- |
| 2026-08-09 | Paul Martin | Independent Director | Other Derivative Acquisition | +1,506 | $238.91 |
| 2026-08-09 | Nirav Shah | Independent Director | Other Derivative Acquisition | +512 | -- |
| 2026-08-09 | Nirav Shah | Independent Director | Other Derivative Acquisition | +1,506 | $238.91 |
| 2026-08-09 | Louis Shapiro | Independent Director | Other Derivative Acquisition | +1,025 | -- |
| 2026-08-09 | Christopher Holland | Independent Director | Other Derivative Acquisition | +1,025 | -- |
| 2026-08-09 | Pierre Boulud | Director | Other Derivative Acquisition | +1,025 | -- |
| 2026-08-09 | Esther Alegria | Independent Director | Other Derivative Acquisition | +512 | -- |
| 2026-08-09 | Esther Alegria | Independent Director | Other Derivative Acquisition | +1,506 | $238.91 |
| 2026-06-30 | Mohsen Sohi | Independent Chairperson | Derivative Exercise and Sale | -1,837 | $71.40–212.30 |
| 2026-06-30 | Mohsen Sohi | Independent Chairperson | Derivative Exercise and Retained | +1,944 | $71.40 |
| 2026-06-14 | John Zangerle | Senior Vice President | Open Market Disposition | -1,419 | $209.28 |
| 2026-06-04 | Daniel Carestio | Chief Executive Officer | Open Market Disposition | -4,428 | $212.00–214.64 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.